Game-changing HIV prevention shot may soon be made in India
Approved in the US as the world’s first twice-yearly HIV prevention shot, lenacapavir is now set to be made in India at a fraction of the cost. It’s a breakthrough that could transform prevention, access and adherence if rolled out swiftly
